Gelteq Ltd (GELS)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $0.44
- As of
Kresmion compiles this page from GELS's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Gelteq Ltd (GELS): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-07-06.
See the full GELS dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for GELS on one page. Preview it with sample data, then open it live with a free account.
Preview the GELS dossierActive events for GELS
- medium13F: new position
CITADEL ADVISORS LLC new position in GELS
- high13F: large reduction
TWO SIGMA INVESTMENTS, LP cut 80% of GELS (2026Q1)
FREE, NO ACCOUNT
Every event on GELS, as it fires
New filings, 13F moves and cross asset events on GELS land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
GELS positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| CITADEL ADVISORS LLC FundCUSIP Q3978B109 · 2026Q2 | $8K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, GELS
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
Going concern statement
GELS's 20-F filed Nov 17, 2025 states:
There is substantial doubt about our ability to continue as a going concern.
Read the 20-F on SEC EDGAR Every company with a going concern statement
More data on GELS
GELS against its peers
GELS's operating margin of -3317.7% ranks in the 17th percentile of 14 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2024-12-31 and 2026-03-31.
| Metric | GELS | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 165645 AUD | n/a | n/a | 0 |
| Gross margin | 30.3% | 49.0% | 21 | 11 |
| Operating margin | -3317.7% | -83.1% | 17 | 14 |
| Net margin | -4011.9% | -22.9% | 17 | 14 |
| Return on equity | -42.0% | -62.0% | 58 | 12 |
Peers (16): SNOA, APUS, YCBD, RDHL, UPC, PRFX, CVSI, CABR, SBFM, AKAN, BFRI, CBIH, BUDZ, CPMD, AYTU, TXMD. Left out: PLSH (period gap), CTTH (period gap), INM (period gap), TRUFF (no annual filing), CNTMF (no annual filing), CANN (period gap), OPTH (no annual filing), PCYN (period gap), CBDL (no annual filing). Fiscal periods ending between 2024-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (GELS: 20-F), reported in AUD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in GELS on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on GELS in the last 180 days.
Upstream: SEC EDGAR filings for GELS
Kresmion, "Gelteq Ltd (GELS) institutional holdings and SEC filings", data as of 2026-08-16, https://kresmion.com/research/GELS. Upstream data: SEC EDGAR filings for GELS.
Link to this data (HTML):
<a href="https://kresmion.com/research/GELS">Gelteq Ltd (GELS) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow GELS on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to GELS for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.